Morgan Stanley

Teva Pharmaceutical Industries is out in the market with a dual tranche euro-denominated bond. Bankers expected the deal to be priced flat to the borrower’s dollar curve.

Akbank has returned to market with a 10 year $500m no grow, its second dollar offering of the year and its second instalment of a $1bn refinancing.

Chinese department store operator Century Ginwa Holdings is looking for a $120m three year amortising loan, with Chang Hwa Bank as sole agent.

Hoist Finance, the Swedish firm specialised in buying and managing unsecured non-performing consumer loans, is today closing the book of its Stockholm IPO.

Harmonicare Medical Holdings is looking to raise between $150m-$200m in a Hong Kong IPO, making it the third healthcare-related issuer to seek an IPO there in the past week.

GF Securities is making a big splash in the ECM market, opening books for its Hong Kong IPO of up to HK$27.9bn ($3.6bn) on Monday, March 23 and offering a very generous discount to where the company’s A-shares are trading. The bargain buy has resonated well with the market, with cornerstone investors having signed up for more than half of the entire trade.

Indian budget airline IndiGo is aiming for a listing in the second quarter of this year, via a deal expected to raise between $400m and $500m, say sources close to the situation.

Vistra Group is looking to list in Hong Kong, hiring JP Morgan and Morgan Stanley as its lead bankers.

Thursday’s accelerated bookbuild action comprised the first block trade in Com Hem, the Swedish cable company, since its IPO.

Equity accelerated bookbuild activity was lively this week, reflecting generally buoyant stock markets and investors eager for paper as quantitative easing begins to bite.

In a busy night of block trade activity on Monday, the standout deal — though not the biggest — was a 9.98% capital increase by Delta Lloyd, the Dutch insurance company.

George Osborne, UK chancellor of the exchequer, handed equity capital markets bankers a windfall on Wednesday — at least in terms of volume and league table credit, if not generous fees.